233 related articles for article (PubMed ID: 6598941)
1. [Small doses of ARA-C in the treatment of myeloblastic leukemia and blast crisis of myelocytic leukemia].
Górski J; Kicińska M; Cenian E
Acta Haematol Pol; 1984; 15(3-4):167-70. PubMed ID: 6598941
[No Abstract] [Full Text] [Related]
2. [High doses of cytosine arabinoside in the treatment of refractory leukemia].
Klener P; Háber J; Kolesková E
Sb Lek; 1987 Sep; 89(8-9):271-5. PubMed ID: 3478794
[No Abstract] [Full Text] [Related]
3. [Small dose of ARA-C in the treatment of an elderly patient with acute myeloblastic leukemia].
Takeyama H; Yano K; Ohoshima K; Satake T; Emi N; Sugihara T; Kawashima K
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2418-22. PubMed ID: 6579883
[TBL] [Abstract][Full Text] [Related]
4. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of myelocytic leukemia during blast transformation (preliminary report)].
Frinovskaia IV; Bogomolova LV
Sov Med; 1976 Aug; (8):28-32. PubMed ID: 1070163
[No Abstract] [Full Text] [Related]
7. [Clinical, cytochemical and immunological characteristics of the blast crisis in myelocytic leukemia].
Vygovskaia IaI; Loginskiĭ VE; Shnitsar EV; Mazurok AA
Ter Arkh; 1983; 55(8):26-30. PubMed ID: 6579695
[No Abstract] [Full Text] [Related]
8. Extramedullary myeloblastic transformation of chronic myelocytic leukemia. Lymph node infiltration one year before marrow blastic change.
Woodson DL; Bennett DE; Sears DA
Arch Intern Med; 1974 Sep; 134(3):523-6. PubMed ID: 4527801
[No Abstract] [Full Text] [Related]
9. Curative effect of harringtonine semisynthetic harringtonine and HOAP on nonlymphocytic leukemias. Analysis of 304 cases.
Zhang ZY; Hou CH; Zhu YF; You XY; Li JL; Fu Z
Chin Med J (Engl); 1987 Jul; 100(7):565-8. PubMed ID: 3123163
[No Abstract] [Full Text] [Related]
10. [Results of the treatment of myeloblastic crisis in myelocytic leukemia using the HAR program].
Zdziechowska H; Niemierko E; Takiel M; Konopka L; Pawelski S
Acta Haematol Pol; 1986; 17(3-4):91-5. PubMed ID: 3473887
[No Abstract] [Full Text] [Related]
11. [Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine].
Waage A; Hammerstrøm J; Lødemel B; Hoff JE; Langtind J
Tidsskr Nor Laegeforen; 1986 Feb; 106(6):496-7. PubMed ID: 3457484
[No Abstract] [Full Text] [Related]
12. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia.
Sutoh H; Yamauchi T; Gotoh N; Sugiyama M; Ueda T
Anticancer Res; 2003; 23(6D):5037-42. PubMed ID: 14981964
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].
Brodzki LM
Acta Haematol Pol; 1985; 16(1-2):85-9. PubMed ID: 3914171
[No Abstract] [Full Text] [Related]
15. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
[No Abstract] [Full Text] [Related]
17. [Cytosine-arabinoside in the treatment of acute myeloblastic leukemias].
Maroncelli P; Canova R; Casalino C; Fischioni P
Minerva Med; 1971 Mar; 62(21):1110-9. PubMed ID: 5279670
[No Abstract] [Full Text] [Related]
18. [A case of acute myelocytic leukemia in relapse controlled by continuous home administration of Ara-C].
Takimoto Y; Imanaka F; Kouzai K; Okuhara T
Gan To Kagaku Ryoho; 1996 Mar; 23(4):495-8. PubMed ID: 8678505
[TBL] [Abstract][Full Text] [Related]
19. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
[TBL] [Abstract][Full Text] [Related]
20. [Case of full remission of a blast crisis in myelocytic leukemia].
Kondrak R; Wedrychowicz A
Wiad Lek; 1981 Mar; 34(6):507-10. PubMed ID: 6943867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
